Hyperprolactinemia as the first symptom of craniopharyngioma

Child'S Brain
|January 1, 1982
PubMed

Insights

Craniopharyngiomas can cause varied hormonal changes, not just panhypopituitarism. Dynamic prolactin evaluation aids early diagnosis in children with these tumors.

Area of Science:

  • Pediatric Endocrinology
  • Neuro-oncology
  • Sellar Region Tumors

Background:

  • Craniopharyngiomas often present with panhypopituitarism, leading to growth failure or pubertal delay in children.
  • The diencephalic control of pituitary prolactin (PRL) secretion is complex and can be affected differently by tumor compression.
  • Varied endocrinological presentations necessitate a nuanced diagnostic approach.

Observation:

  • A dynamic prolactin (PRL) evaluation was performed pre- and post-operatively in four pediatric craniopharyngioma patients.
  • Hormonal profiles were correlated with tumor size, location, and surgical outcomes.
  • Clinical symptoms like growth failure and pubertal delay were noted.

Findings:

  • Different endocrinological pictures, beyond panhypopituitarism, were observed due to varying degrees of pituitary-hypothalamic compression.
  • Dynamic PRL evaluation provided insights into the hormonal impact of craniopharyngiomas.
  • Tumor characteristics influenced the observed hormonal alterations.

Implications:

  • Dynamic prolactin assessment can be a valuable tool for the early diagnosis of pediatric craniopharyngiomas.
  • Understanding varied hormonal profiles aids in tailoring treatment and monitoring surgical success.
  • This study highlights the importance of considering diverse endocrinological manifestations in suspected craniopharyngioma cases.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...